NCSL: Aug. 9 Panel Sessions

Attend these sessions to hear from Pew experts

Sections

NCSL: Aug. 9 Panel Sessions

Prescription Drugs and Costs: Challenges and Opportunities

11 am – 12:15 pm
W187

Break-through products such as biologics and specialty drugs promise extended lives or first-ever cures for individuals. Yet some price tags in this $310 billion U.S. market have shocked those who foot the bill—including state governments, Medicaid, employers, health insurers and patients themselves. States are considering a variety of legislation to rein in costs, assist consumers or shift the burden. Terms such as "medically necessary," "medication adherence," "fail first," "preferred drug lists," "value-based purchasing" and "interchangeable biosimilar substitution" make state capitals sound like pharmacies. Hear state and medical experts sort out the headlines, the noise and the results so far.

  • Panelist: Richard Ascroft, JD, RPh, Takeda Pharmaceuticals U.S.A. for PhRMA, Illinois
  • Panelist: Stephen Fitton, Health Management Association/Former Michigan Medicaid, Michigan
  • Panelist: Chuck Shih, PHD, The Pew Charitable Trusts, Washington, D.C.

Improving End-of-Life Care: A Better End

12:15-1:30 pm
W185bc

With advances in modern medicine, Americans face more options regarding the care they receive at the end of life. In this lunch session, hear about a range of topics related to end-of-life decisions and empowering individuals.

  • Speaker: Amy Vandenbroucke, The National POLST Office, Oregon, consultant to The Pew Charitable Trusts
America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.